ICARES Medicus, Inc. (TPEX:6612)

Market Cap	5.43B
Revenue (ttm)	742.27M
Net Income (ttm)	66.08M
Shares Out	42.57M
EPS (ttm)	1.55
PE Ratio	82.41
Forward PE	n/a
Dividend	0.18 (0.14%)
Ex-Dividend Date	Jul 8, 2024

Volume	25,532
Average Volume	30,138
Open	127.50
Previous Close	126.50
Day's Range	127.00 - 128.50
52-Week Range	96.36 - 177.00
Beta	0.74
RSI	54.24
Earnings Date	Mar 14, 2025

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the design, research, development, manufacture, and sale of intraocular lenses and nanomedical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company offers ophthalmic medical devices, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, and astigmatism; and surgical implant systems, as well as related technical services. It also provides nanomedical lubricious coatings and various surface treatments...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6612

Financial Performance

In 2023, ICARES Medicus's revenue was 605.45 million, an increase of 18.29% compared to the previous year's 511.85 million. Earnings were 97.73 million, a decrease of -24.19%.